JGAB LTD
Company number 13758271 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JGAB LTD - Analysis Report
Company Number: 13758271
Analysis Date: 2025-07-29 20:42 UTC
Financial Health Assessment of JGAB LTD
1. Financial Health Score: B+
Explanation:
JGAB Ltd demonstrates a solid financial position with strong net assets and positive working capital, indicative of good liquidity and financial stability typical of a healthy micro-entity. However, some slight concerns arise from a decrease in current assets and an increase in fixed assets that warrant monitoring to ensure cash flow remains robust. Overall, the company's financial "vital signs" suggest it is in good health but should continue prudent management to maintain this.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 29,811 | Increased investment in long-term assets indicates growth or capital expenditure. |
| Current Assets | 72,625 | Represents liquid resources; slight decrease from prior year but still healthy. |
| Current Liabilities | 8,275 | Low short-term debt load, reducing risk of liquidity strain. |
| Net Current Assets | 64,350 | Strong positive working capital; indicates good ability to cover short-term obligations. |
| Net Assets (Equity) | 94,161 | Robust equity base reflects overall financial strength and retained earnings. |
| Employee Count | 2 | Small team consistent with micro-entity classification and specialist practice. |
Interpretation of Vital Signs:
- Healthy Cash Flow Buffer: The company’s net current assets of £64,350 signal a comfortable liquidity buffer, akin to a healthy pulse and stable blood pressure in a medical check. This suggests the business can meet its immediate financial obligations without distress.
- Asset Growth: The almost sixfold increase in fixed assets from £4,784 to £29,811 could represent investment in medical equipment or premises, important for a specialist medical practice. While this is a positive sign of growth ("building muscle"), it requires matching cash flow to avoid liquidity strain.
- Stable Equity: The increase in net assets from £77,647 to £94,161 reflects retained profitability and financial resilience.
3. Diagnosis: Financial Condition Overview
JGAB Ltd exhibits the financial "vital signs" of a well-managed, financially stable micro-entity. The company maintains a strong liquidity position and a growing asset base, which supports operational effectiveness in its specialist medical practice field.
Strengths:
- Strong working capital ensures the company can comfortably cover its short-term liabilities, minimizing risk of cash flow problems.
- Growing fixed assets show asset base expansion, possibly improving service capacity or competitive positioning.
- Equity growth demonstrates the company is retaining earnings and strengthening its financial foundation.
- No overdue filings or compliance issues, indicating good governance and operational discipline.
Potential Concerns ("Symptoms" to Monitor):
- The drop in current assets from £87,696 in 2023 to £72,625 in 2024 could indicate increased cash outflows or reduced receivables; it’s important this does not continue to decline as it could signal tightening liquidity.
- The jump in fixed assets needs to be matched by sustainable cash flow generation; otherwise, the company could exhibit symptoms of overextension.
- Small employee base means operational capacity and succession risk should be monitored.
4. Recommendations
- Maintain Healthy Liquidity: Continue to monitor cash flow closely, ensuring that the investment in fixed assets does not constrain operating cash. Implement cash flow forecasting to anticipate any liquidity shortfalls.
- Asset Utilization Review: Regularly assess the return on new fixed assets (e.g., equipment) to ensure they contribute positively to revenue and profitability, avoiding “dead weight” on the balance sheet.
- Growth Planning: Explore gradual scaling strategies that match operational capacity, maintaining financial resilience without over-leveraging.
- Compliance and Governance: Keep up with timely filings and maintain robust internal controls to avoid regulatory "health risks."
- Succession and Risk Management: Given the small team size, consider contingency plans for key personnel absence or turnover to avoid operational disruptions.
Summary
JGAB Ltd is financially healthy with strong liquidity and growing assets, reflecting a stable and expanding specialist medical practice. While the company shows positive signs of financial “wellness,” it should continue prudent cash flow management and asset utilization to sustain this trajectory.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.